Trial Sites for the HEALEY ALS Platform Trial
Sean M. Healey & AMG Center for ALS Announces the Names of 54 Selected Sites for the HEALEY ALS Platform Trial
The Sean M. Healey & AMG Center at Massachusetts General Hospital, in collaboration with the Northeast ALS Consortium (NEALS), is launching the first platform trial for amyotrophic lateral sclerosis (ALS). The goals of this groundbreaking project are to greatly accelerate the timelines towards effective ALS treatments and provide greater trial access for all those affected by this disease. Visit the trial page on ClinicalTrials.gov for more information about sites and trial participation criteria.
The HEALEY ALS Platform Trial is a collaborative effort and enrollment in the trial will be available at several sites across the U.S. to bring the trial close to people who want to participate. All sites are part of the NEALS Consortium. See below for a list of participating sites.
For more information, please email HEALEYALSPlatform@mgh.harvard.edu.
Map of Participating Sites
List of Participating Sites by State
|
Site |
State |
Contact Information |
|
Barrow Neurological Institute |
Arizona |
Jessie Duncan |
|
Forbes Norris MDA/ALS Research Center, California Pacific Medical Center |
California |
Marguerite Engel |
|
University of California, Irvine |
California |
Vivian Li |
|
Cedars-Sinai Medical Center |
California |
Carolyn Prina |
|
Loma Linda University Health |
California |
Blanca Herrera |
|
University of Colorado Anschutz |
Colorado |
Brianna Blume |
|
Hospital for Special Care |
Connecticut |
Natalie Schmitt |
|
Phil Smith Neuroscience Institute at Holy Cross Hospital |
Florida |
Donovan Mott |
|
Mayo Clinic Florida |
Florida |
Lisa Thuro |
|
University of Florida Gainesville |
Florida |
Jennifer Steshyn |
|
University of Miami |
Florida |
Wendy Levy |
|
University of South Florida College of Medicine |
Florida |
Jessica Shaw |
|
Emory University |
Georgia |
Meraida Polak |
|
University of Chicago |
Illinois |
Shail Bhatnagar |
|
Northwestern University |
Illinois |
Ben Joslin |
|
University of Iowa Hospitals and Clinics |
Iowa |
Jeri Sieren |
|
University of Kansas Medical Center |
Kansas |
Andrew Heim |
|
University of Kentucky |
Kentucky |
Meg Bruno |
|
Ochsner Health Systems |
Louisiana |
Kristina Brown |
|
Johns Hopkins University |
Maryland |
Kristen Riley |
|
University of Maryland |
Maryland |
Vikram Nambiar |
|
Beth Israel Deaconess Medical Center |
Massachusetts |
Hilda Guitierrez |
|
Massachusetts General Hospital |
Massachusetts |
Danny Hevert |
|
University of Massachusetts Medical School, Worcester |
Massachusetts |
Diane McKenna-Yasek |
|
Henry Ford Health System |
Michigan |
Anne Vallis |
|
University of Michigan |
Michigan |
Jayna Duell |
|
Spectrum Health |
Michigan |
Nichole Roderique |
|
Mayo Clinic Rochester |
Minnesota |
Carol Denny |
|
University of Minnesota/Twin Cities ALS Research Consortium |
Minnesota |
Valerie Ferment |
|
University of Missouri Health Care |
Missouri |
Natalie Taylor |
|
Saint Louis University |
Missouri |
Susan Brown |
|
Washington University School of Medicine |
Missouri |
Elizabeth Karanja |
|
University of Nebraska Medical Center |
Nebraska |
Renee Hogue |
|
Neurology Associates, P.C./Somnos Clinical Research |
Nebraska |
Desirae Eschiti |
|
Dartmouth-Hitchcock Medical Center |
New Hampshire |
Caren Saunders |
|
Columbia University |
New York |
Jessica Singleton |
|
SUNY Upstate |
New York |
Jacob Pusey |
|
Duke University |
North Carolina |
Lisa Harrison |
|
Wake Forest University Health Sciences |
North Carolina |
Mozhdeh Marandi |
|
The Ohio State University |
Ohio |
Erin Cohen |
|
Providence Brain and Spine Institute ALS Center |
Oregon |
Arlena Cummings |
|
University of Pennsylvania |
Pennsylvania |
Adreeja Guharay |
|
Lewis Katz School of Medicine at Temple University |
Pennsylvania |
Kathleen Hatala |
|
Jefferson Weinberg ALS Center, Thomas Jefferson University |
Pennsylvania |
Laura Oakley |
|
Penn State Hershey |
Pennsylvania |
Anne Haulman |
|
Medical University of South Carolina |
South Carolina |
Katrina Madden |
|
Vanderbilt University Medical Center |
Tennessee |
Diana Davis |
|
Wesley Neurology Clinic |
Tennessee |
Cindy Benzel |
|
University of Texas Health Science Center at San Antonio (UTHSCSA) |
Texas |
Pamela Kittrell |
|
Houston Methodist |
Texas |
Sharon Halton |
|
Texas Neurology |
Texas |
Todd Morgan |
|
University of Virginia |
Virginia |
Mary Wagoner |
|
University of Washington |
Washington |
Laura Sissons-Ross |
|
Medical College of Wisconsin |
Wisconsin |
Marie Mejaki |
HEALEY ALS Platform Trial Indirect Cost Policy
In executing the Master Clinical Trial Agreement (MCTA) to participate in the HEALEY ALS Platform Trial, Sites agree they will be paid indirect costs (IDC) at the rate at which the originating funding organization reimburses MGH. For payments made from internal MGH philanthropic funds, the IDC will be capped at 15% of total direct costs.
Reference Papers on Innovative Trial Design
Platform trials are trials where multiple drugs are tested at the same time, using specialized statistical tools.
Work With Us
Researchers interested in testing a therapy in the HEALEY ALS Platform Trial should contact us to discuss collaboration. We look forward to hearing from you.